Skip to main
OPCH
OPCH logo

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health Inc. has demonstrated a solid financial performance with its gross profit reaching $269.0 million, representing an 8% year-over-year increase and surpassing previous estimates. In addition, the company has revised its revenue projections for 2025 upwards to a range of $5.5 billion to $5.65 billion, reflecting a 12% growth year-over-year at the midpoint. These strong financial metrics indicate a robust operational strategy and a positive outlook for the company's future growth trajectory.

Bears say

Option Care Health Inc faces significant revenue risk due to its reliance on a single customer, which represents 14% of its 2023 revenue; the potential loss of this customer could substantially impact both revenue and profitability. Additionally, the company's gross margin expansion appears constrained as the growth of lower-margin chronic therapies outpaces that of higher-margin acute therapies, posing challenges for future EBITDA margin improvement. Furthermore, any merger and acquisition activities beyond its core operations may introduce execution risks and negatively affect market sentiment, hampering near-term growth and margin stability.

OPCH has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 8 analysts, OPCH has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.